Low triiodothyronine syndrome is associated with stroke‐associated pneumonia

• Published in: European journal of clinical investigation Vol. 52; no. 11
• Main Authors: Chen, Huijun, Xu, Minjie, Huang, Yezhi, He, Jincai, Ren, Wenwei
• Format: Journal Article
• Language: English
• Published: Oxford Blackwell Publishing Ltd 01.11.2022
• Subjects: Confidence intervals; Disease control; Hormones; ischaemic stroke; Ischemia; low syndrome; Patients; Pneumonia; Risk analysis; Risk factors; Stroke; stroke‐associated pneumonia; Thyroid; Thyroid gland; Thyroid hormones; Thyroid-stimulating hormone; Triiodothyronine
• ISSN: 0014-2972; 1365-2362
• DOI: 10.1111/eci.13840

Objective Stroke‐associated pneumonia (SAP) is the most common early consequence in patients suffering from an acute ischaemic stroke (AIS). The purpose of this study was to explore the possible relationship between low triiodothyronine (T3) syndrome and SAP in stroke patients. Methods This study recruited 2460 consecutive AIS patients. SAP was defined according to the modified Centers for Disease Control and Prevention criteria for hospital‐acquired pneumonia. The thyroid hormones levels were measured within 24 h after admission. Low T3 syndrome was characterized as T3 below the lower limit of the reference interval accompanied by normal TSH levels. Results Among the total patients, 336 (13.7%) patients were diagnosed with SAP. SAP in individuals with low T3 syndrome was substantially greater (p < .001) as compared to those without low T3 syndrome. After adjusting for possible confounders, low T3 syndrome (adjusted odds ratio [aOR] = 1.59; 95% confidence interval [CI], 1.20–2.09; p = .001) remained significant in our logistic model. Patients with low T3 syndrome had a higher risk of severe SAP (aOR = 2.17, 95% confidence interval [CI] 1.38–3.44; p = .001). Conclusion Low T3 syndrome, independent of recognized risk factors, is a possible risk factor for in‐hospital SAP, which can help clinicians in the early detection and treatment of high‐risk patients.